Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet a light

Transfusion

Volumn 44, Issue 12, 2004, Pages 1732-1740

  Snyder, Edward ^b   Raife, Thomas ^b   Lin, Lily ^b   Cimino, George ^b   Metzel, Peyton ^b   Rheinschmidt, Margaret ^b   Baril, Laurene ^b   Davis, Kathryn ^b   Buchholz, D H ^b   Corash, Laurence ^b   Conlan, Maureen G ^a  

^a CERUS CORPORATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOTOSALEN; INDIUM 111; PSORALEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GAMMA IRRADIATION; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; NORMAL HUMAN; THROMBOCYTE LIFESPAN; ULTRAVIOLET A RADIATION;

ADOLESCENT; ADULT; BLOOD PLATELETS; FEMALE; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PSORALENS; ULTRAVIOLET RAYS;

EID: 10444279184     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2004.04145.x     Document Type: Article

References (34)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
2. Luban NL. Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components. Semin Hematol 2001;38(Suppl 11):34-45.
3. Wollowitz S. Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin Hematol 2001;38(Suppl 11):4-11.
4. Lin L, Cook DN, Wiesehahn GP, et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997;37:423-35.
5. Lin L, Alfonso R, Behrman B, et al. Photochemical treatment of platelet concentrates with a novel psoralen and UVA to enhance the safety of platelet transfusions. Infus Ther Transfus Med 1998;25:39-48.
6. Grass JA, Hei DJ, Metchette K, et al. Inactivation of leukocytes in platelet concentrates by psoralen plus UVA. Blood 1998;91:2180-8.
7. Jansen G, van Vliet H, Vermeij H, et al. Functional characteristics of photochemically treated platelets. Transfusion 2004;44:313-9.
8. Murphy S, Rebulla P, Bertolini F, et al. In vitro assessment of the quality of stored platelet concentrates. Transfus Med Rev 1994;8:29-36.
9. Rock G, Tittley P, Adams G. Donor variables affecting survival of autologous platelets. Transfusion 1986;26: 30-6.
10. 51Cr allows accurate evaluation of platelet viability of stored platelet concentrates. Br J Haematol 1993;84:717-23.
11. Lotter MG, Heyns AP, Badenhorst PN, et al. Evaluation of mathematic models to assess platelet kinetics. J Nucl Med 1986;27:1192-201.
12. Kunicki TJ, Tuccelli M, Becker GA, Aster RH. A study of variables affecting the quality of platelets stored at room temperature. Transfusion 1975;15:414-21.
13. Handin RI, Fortier NL, Valeri CR. Platelet response to hypotonic stress after storage at 4 or 22°C. Transfusion 1970;10:305-9.
14. Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Oxford: Blackwell Scientific Publications; 1987.
15. 51Cr-labelled platelets: a comparative study using both stored and fresh platelets. Br J Haematol 1991;78:523-8.
16. Dumont LJ, Beddard R, Whitley P, et al. Autologous transfusion recovery of WBC-reduced high-concentration platelet concentrates. Transfusion 2002;42:1333-9.
17. Holme S, Heaton WAL, Whitley P. Platelet storage lesions in second-generation containers: correlation with in vivo behavior with storage up to 14 days. Vox Sang 1990;59:12-8.
18. Holme S, Heaton WA, Moroff G. Evaluation of platelet concentrates stored for 5 days with reduced plasma volumes. Transfusion 1994;34:39-43.
19. Holme S, Heaton WA, Smith KT, Buchholz DH. Evaluation of apheresis platelet concentrates collected with a reduced (30-ml) collection chamber with resuspension and storage in a synthetic medium. Vox Sang 1994;67:149-53.
20. Holme S, Heaton A. In vitro platelet ageing at 22°C is reduced compared to in vivo ageing at 37°C. Br J Haematol 1995;91: 212-8.
21. 51Cr. Transfusion 1992;32:113-20.
22. Moroff G, Holme S, George VM, Heaton WA. Effect on platelet properties of exposure to temperatures below 20°C for short periods during storage at 20-24°C. Transfusion 1994;34:317-21.
23. Murphy S, Kagen L, Holme S, et al. Platelet storage in synthetic media lacking glucose and bicarbonate. Transfusion 1991;31:16-20.
24. Sherman L, Menitove J, Kagen LR, et al. Ultraviolet-B irradiation of platelets: a preliminary trial of efficacy. Transfusion 1992;32:402-7.
25. Simon T, Lee EJ, Heaton A, et al. Storage and transfusion of platelets collected by an automated two-stage apheresis procedure. Transfusion 1992;32:624-8.
26. Snyder EL, Ezekowitz M, Aster R, et al. Extended storage of platelets in a new plastic container II: in vivo response to infusion of platelets stored for 5 days. Transfusion 1985;25:209-14.
27. Snyder EL, Aster RH, Heaton A, et al. Five-day storage of platelets in a non-diethyl hexyl phthalate-plasticized container. Transfusion 1992;32:736-41.
28. Sweeney JD, Holme S, Moroff G. Storage of apheresis platelets after gamma irradiation. Transfusion 1994;34:779-83.
29. Sweeney JD, Holme S, Stromberg RR, Heaton WA. In vitro and in vivo effects of pre storage filtration of apheresis platelets. Transfusion 1995;35:125-30.
30. Dumont LJ, AuBuchon JP, Whitley P, et al. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 2002;42:847-54.
31. Grass JA, Wafa T, Reames A, et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 1999;93:3140-7.
32. Button NL, DeWolf WC, Newberger PE, Jacobson MS, Kevy SV. The effect of irradiation on blood components. Transfusion 1981;21:419-26.
33. McCullough J, Vesole D, Benjamin R, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004;104:1534-41.
34. van Rhenen D, Gulliksson H, Cazenave JP, et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE Trial. Blood 2003;101:2426-33.